Tutorials › Pharmacokinetic-Pharmacodynamic (PK/PD) Modeling › Dissociation Constants and Affinity Scales

Target Binding, Occupancy and Engagement · Tutorial 218 of 598

Dissociation Constants and Affinity Scales

Interpret and convert Kd and Ka, compare affinity on concentration or logarithmic scales, and distinguish these constants from total ligand concentration and assay potency.

Advanced 10 min read

What You'll Learn

  • Define Kd and Ka for reversible 1:1 target binding at equilibrium.
  • Convert between dissociation and association constants with consistent units.
  • Compare affinity values and interpret pKd without reversing the scale.
  • Use free ligand concentration when relating concentration to equilibrium occupancy.
  • Explain why total concentration and assay potency are not interchangeable with Kd.
  • Recognize assumptions and common interpretation problems in affinity comparisons.

Why Affinity Constants Need Careful Interpretation

A binding constant is a compact summary of how a ligand and target are distributed between unbound and bound forms at equilibrium. It is useful for comparing ligands, interpreting equilibrium occupancy, and communicating a concentration scale. But the number is meaningful only when its definition, units, and experimental context are clear. In particular, the concentration used in the equilibrium relation is the free ligand concentration, not automatically the amount of ligand added to an assay.

This tutorial considers reversible binding of one ligand to one target site. It focuses on the equilibrium dissociation constant \(K_d\), the association constant \(K_a\), and the limits of interpreting them as measures of affinity. These equilibrium constants do not by themselves describe how quickly binding occurs or how long a ligand remains bound.

Definitions and the Reciprocal Relationship

Let \(R\) denote unbound target, \(L\) unbound ligand, and \(RL\) the target–ligand complex. For a reversible 1:1 interaction at equilibrium, the concentration-based dissociation constant is defined by the equilibrium concentrations of these three species.

$$ K_d = \frac{[R][L]_{\mathrm{free}}}{[RL]} $$

Here, brackets denote concentration, and \([L]_{\mathrm{free}}\) is the concentration of unbound ligand. With all concentrations expressed in molar units, \(K_d\) has units of concentration, such as M, μM, or nM. A smaller \(K_d\) means that a lower free ligand concentration is associated with a given equilibrium ratio of bound to unbound target; in the usual sense, it indicates higher affinity.

The association constant is the reciprocal concentration-based constant:

$$ K_a = \frac{[RL]}{[R][L]_{\mathrm{free}}} = \frac{1}{K_d} $$

Under this convention, \(K_a\) has units of inverse concentration, such as M\(^{-1}\). A larger \(K_a\) indicates higher affinity. The units matter: a value reported as \(K_d=10\) nM is not numerically interchangeable with \(K_a=10\) M\(^{-1}\). Convert to a common concentration unit before taking a reciprocal or comparing values.

Definition: For reversible 1:1 binding at equilibrium, \(K_d\) is the ratio of unbound target times free ligand concentration to complex concentration. \(K_a\) is its reciprocal. Lower \(K_d\) and higher \(K_a\) both indicate higher affinity, provided the constants use the same convention and refer to comparable conditions.

These definitions assume the system has reached equilibrium; the binding is reversible; the interaction is adequately represented by one ligand binding one target site; and concentrations represent the relevant binding species. The interpretation also assumes that experimental conditions such as temperature, pH, buffer, and target state are specified and sufficiently comparable. In practice, concentration-based constants treat concentrations as proxies for chemical activities. The approximation and the assay method can matter when comparing measurements across substantially different conditions.

For this simple binding model, fractional occupancy \(\theta\), the fraction of target sites occupied, is related to free ligand concentration by:

$$ \theta = \frac{[L]_{\mathrm{free}}}{K_d + [L]_{\mathrm{free}}} $$

This expression makes the scale interpretation explicit: when free ligand concentration equals \(K_d\), occupancy is one-half. Thus \(K_d\) is the free ligand concentration associated with 50% occupancy in this equilibrium model. This does not mean every assay reporting a 50% effect measures \(K_d\); the measured quantity and model must actually correspond to equilibrium binding occupancy.

Converting Constants and Comparing Affinity

To convert \(K_d\) to \(K_a\), first express \(K_d\) in the concentration unit whose reciprocal is desired. For example, \(1\) nM is \(10^{-9}\) M, so a \(K_d\) written in nM must be converted to M before reporting \(K_a\) in M\(^{-1}\). Alternatively, retain reciprocal units explicitly: \(K_d=20\) nM corresponds to \(K_a=0.05\) nM\(^{-1}\), which is \(5.00\times10^7\) M\(^{-1}\).

Comparisons are easiest when all \(K_d\) values use the same unit. For example, \(0.2\) μM is \(200\) nM; it is not smaller than \(50\) nM simply because the number “0.2” is smaller than “50.” On the \(K_d\) scale, smaller values mean stronger affinity. On the \(K_a\) scale, the order reverses: larger values mean stronger affinity.

A logarithmic scale is also common. Define \(pK_d=-\log_{10}(K_d/\mathrm{M})\), where the ratio inside the logarithm is dimensionless. Because of the negative sign, larger \(pK_d\) means smaller \(K_d\), and therefore higher affinity. A one-unit increase in \(pK_d\) corresponds to a tenfold decrease in \(K_d\). The logarithmic scale can make comparisons across orders of magnitude easier, but it does not change the underlying definition.

Worked Example: Converting a Dissociation Constant to Ka

Suppose a hypothetical equilibrium binding experiment estimates \(K_d=25.0\) nM. Calculate \(K_a\) in M\(^{-1}\), and check the units.

First convert the dissociation constant to molar units:

$$ K_d = 25.0\ \mathrm{nM} = 25.0 \times 10^{-9}\ \mathrm{M} = 2.50 \times 10^{-8}\ \mathrm{M} $$

Take the reciprocal:

$$ K_a = \frac{1}{K_d} = \frac{1}{2.50 \times 10^{-8}\ \mathrm{M}} = 4.00 \times 10^{7}\ \mathrm{M}^{-1} $$

The reciprocal of concentration has units M\(^{-1}\), as required. Equivalently, \(K_a=0.0400\) nM\(^{-1}\). The two numerical forms differ because their concentration units differ; they represent the same constant.

Worked Example: Ranking Two Ligands by Affinity

Two hypothetical ligands are measured against the same target under comparable equilibrium conditions. Ligand A has \(K_d=8.00\) nM, and ligand B has \(K_d=0.400\) μM. Which has higher affinity, and by what factor on the \(K_d\) scale?

Convert ligand B’s value to nM:

$$ 0.400\ \mathrm{\mu M} \times 1000\ \frac{\mathrm{nM}}{\mathrm{\mu M}} = 400\ \mathrm{nM} $$

The lower \(K_d\) belongs to ligand A, so ligand A has higher affinity in this comparison. The ratio of the dissociation constants is:

$$ \frac{K_{d,B}}{K_{d,A}} = \frac{400\ \mathrm{nM}}{8.00\ \mathrm{nM}} = 50.0 $$

Thus ligand B’s \(K_d\) is 50-fold higher than ligand A’s. In reciprocal units, \(K_{a,A}=1/(8.00\times10^{-9}\ \mathrm{M})=1.25\times10^8\ \mathrm{M}^{-1}\), whereas \(K_{a,B}=1/(4.00\times10^{-7}\ \mathrm{M})=2.50\times10^6\ \mathrm{M}^{-1}\). Ligand A’s \(K_a\) is also 50-fold higher. Both scales give the same ranking when interpreted in the correct direction.

Free Concentration, Total Concentration, and Occupancy

The binding equation uses \([L]_{\mathrm{free}}\), because only unbound ligand is available to bind at that instant. Total ligand concentration includes ligand in all relevant forms, including free and bound ligand. Consequently, the total concentration added to an assay need not equal the free concentration during the measurement. They may be close when binding removes only a negligible fraction of ligand from solution, but that cannot be assumed from the reported dose alone.

When free concentration is measured or otherwise appropriately estimated, it can be used in the occupancy equation. Substituting total concentration in its place without justification can produce a misleading occupancy estimate. A complete treatment of how free and total concentrations are linked requires a binding mass balance; the key point here is that they are distinct quantities.

Worked Example: Using Free Rather Than Total Concentration

In a hypothetical equilibrium system, \(K_d=10.0\) nM. The free ligand concentration is measured as \(30.0\) nM, while the total ligand concentration in the sample is \(100\) nM. Calculate occupancy using the stated model, and show what goes wrong if total concentration is substituted for free concentration.

Using the measured free concentration:

$$ \theta = \frac{[L]_{\mathrm{free}}}{K_d+[L]_{\mathrm{free}}} = \frac{30.0\ \mathrm{nM}}{10.0\ \mathrm{nM}+30.0\ \mathrm{nM}} = 0.750 $$

The model gives 75.0% occupancy. If total concentration were incorrectly treated as free concentration, the calculation would instead be:

$$ \theta_{\mathrm{incorrect}} = \frac{100\ \mathrm{nM}}{10.0\ \mathrm{nM}+100\ \mathrm{nM}} = 0.909 $$

That is 90.9%, not 75.0%. The difference arises from using the wrong concentration in the equation, not from a change in \(K_d\). The example does not prescribe how to obtain free concentration; it illustrates why the distinction must be preserved.

Affinity Is Not Assay Potency

An assay potency value describes the concentration associated with a specified assay response, such as an \(IC_{50}\) or \(EC_{50}\). A binding \(K_d\), by contrast, describes an equilibrium relationship between free ligand, unbound target, and complex under a binding model. Potency and affinity may be related in a particular experimental system, but they are not interchangeable definitions.

A functional response can depend on more than target occupancy, including the relationship between occupancy and downstream response, assay conditions, and the response endpoint. A displacement assay’s \(IC_{50}\) is also an assay-dependent quantity; it should not be identified with \(K_d\) without the assumptions and conversion appropriate to that assay. Therefore, a potency ranking can differ from a binding-affinity ranking without either measurement being inherently wrong.

Worked Example: Interpreting Potency and Affinity Separately

Two hypothetical compounds are evaluated in separate assays. Compound X has an equilibrium binding \(K_d=20.0\) nM and a functional \(EC_{50}=120\) nM. Compound Y has \(K_d=80.0\) nM and \(EC_{50}=40.0\) nM. State which compound has higher measured binding affinity and which has greater functional potency by \(EC_{50}\).

For binding affinity, compare the \(K_d\) values: \(20.0\) nM is lower than \(80.0\) nM, so compound X has the higher measured affinity in the binding assay. The ratio is \(80.0/20.0=4.00\), so X’s \(K_d\) is fourfold lower.

For functional potency, a lower \(EC_{50}\) means that a lower assay concentration produced the specified half-maximal response. Compound Y’s \(EC_{50}=40.0\) nM is lower than X’s \(120\) nM; the ratio is \(120/40.0=3.00\). Thus Y is threefold more potent by this \(EC_{50}\) comparison. These results do not contradict each other: the binding and functional assays measure different quantities, and the values alone do not establish why their rankings differ.

Diagnostics, Limitations, and a Common Pitfall

Before comparing affinity estimates, check that the values refer to the same target form and a comparable binding model, and that units, temperature, and relevant assay conditions are reported. Inspect whether the method estimates an equilibrium \(K_d\) or reports another endpoint. If the analysis relies on nominal or total ligand concentration, ask whether it is a reasonable proxy for free concentration; if not, the resulting estimate may not represent the defined equilibrium constant. A fitted value should also be interpreted cautiously if the data do not meaningfully constrain the concentration range around the binding transition.

The simple \(K_d\) relationship has limitations. It summarizes equilibrium binding under a specified model; it does not reveal association or dissociation rates, prove that a one-site model is adequate, or determine a downstream effect. Comparisons across different targets or assay environments may reflect differences in conditions or model assumptions as well as differences in ligand binding. For those reasons, report the measured quantity, units, experimental context, and model rather than presenting a bare number as a universal property.

Common mistake: “Compound A has a \(K_d\) of 5 nM and compound B has a \(K_d\) of 50 nM, so B has tenfold higher affinity because its number is larger.” This reverses the \(K_d\) scale. The correction is that smaller \(K_d\) means higher affinity: A’s \(K_d\) is tenfold lower. The opposite numerical direction applies to \(K_a\), where larger values indicate higher affinity.

A second frequent error is to calculate occupancy from the amount of ligand added, without establishing that this is the free concentration. Use \([L]_{\mathrm{free}}\) in the occupancy expression, and distinguish a binding constant from a functional \(EC_{50}\) or assay \(IC_{50}\). Keeping the definition attached to each number prevents most interpretation errors.

Check Your Understanding

Answer each question, then compare your reasoning with the solutions.

  1. A hypothetical ligand has \(K_d=4.00\times10^{-8}\) M. What is \(K_a\) in M\(^{-1}\), and which direction does this \(K_d\) value move if affinity increases?
  2. Ligand P has \(K_d=0.030\) μM and ligand Q has \(K_d=60\) nM. Which has higher affinity, and by what factor are their \(K_d\) values different?
  3. For \(K_d=15\) nM and free ligand concentration \(45\) nM, what occupancy does the 1:1 equilibrium model predict?
  4. Why is it generally incorrect to substitute total ligand concentration for free ligand concentration in the occupancy equation?
  5. A compound has a lower functional \(EC_{50}\) than another compound but a higher measured \(K_d\). Is that necessarily inconsistent? Explain.

Solutions. (1) \(K_a=1/(4.00\times10^{-8}\ \mathrm{M})=2.50\times10^7\ \mathrm{M}^{-1}\). Higher affinity corresponds to a lower \(K_d\). (2) \(0.030\) μM is \(30\) nM; P has the lower \(K_d\), so P has higher affinity, and Q’s \(K_d\) is \(60/30=2.00\) times P’s. (3) \(\theta=45/(15+45)=0.750\), or 75.0%. (4) Total ligand includes ligand that is not free; the binding expression requires unbound ligand concentration, so the substitution is valid only when total is an appropriate proxy for free. (5) No. \(EC_{50}\) measures functional assay potency, whereas \(K_d\) measures equilibrium binding under a binding model; they can have different rankings.

Clinical Biostats